The following factors affect the price of the PBMR.US ETF: Portfolio Holdings' Performance: The underlying assets (primarily biotech and pharmaceutical companies involved in precision medicine) directly influence the ETF's price. Positive or negative news about these companies' drug trials, earnings, or regulatory approvals will impact PBMR.US.

Investor Sentiment: Overall market sentiment toward the healthcare and biotechnology sectors plays a crucial role. Bullish sentiment can drive demand and increase the ETF's price, while bearish sentiment can lead to sell-offs and price declines.

Expense Ratio and Trading Costs: The ETF's expense ratio, along with brokerage commissions and bid-ask spreads, indirectly affects returns. Higher expenses can reduce overall profitability and potentially impact investor demand.

Supply and Demand: The basic economic principle of supply and demand also applies. Increased buying pressure will push the price upward, while increased selling pressure will drive it downward.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can indirectly affect the ETF by influencing investment decisions and the performance of the underlying companies.

Regulatory Changes: Changes in government regulations related to healthcare, drug approvals, and pricing can significantly impact the biotech and pharmaceutical industries, affecting the ETF's value.

Currency Fluctuations: For ETFs holding international assets, currency exchange rates can influence returns. A stronger US dollar can reduce the value of foreign holdings, and vice versa.

Competition: The performance and attractiveness of competing ETFs focused on similar themes (e.g., healthcare innovation or genomics) can influence investor flows into or out of PBMR.US, impacting its price.